- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Alliance for MRI invites you to a reception
On behalf of the Alliance for MRI, Alejandro Cercas MEP, Liz Lynne MEP and Françoise Grossetête MEP invite you to a Drinks Reception with Commissioner László Andor on revising the EMF Directive. The reception will take place Wednesday 29th Sept., from 6.30 to 8.00 p.m. in the European Parliament Members Salon of the Altiero Spinelli Building, European Parliament, at 60 Rue Wiertz, 1050 Brussels.
On behalf of the Alliance for MRI, Alejandro Cercas MEP, Liz Lynne MEP and Françoise Grossetête MEP invite you to a Drinks Reception with Commissioner László Andor on revising the EMF Directive. The reception will take place Wednesday 29th Sept., from 6.30 to 8.00 p.m. in the European Parliament Members Salon of the Altiero Spinelli Building, European Parliament, at 60 Rue Wiertz, 1050 Brussels.
Commissioner László Andor will present the commission’s approach to revise the existing EU Health and Safety Legislation to protect workers from electromagnetic fields (‘EMF’ Directive 2004/40/EC) in order to ensure the future of magnetic resonance imaging (MRI).
The issue
The existing exposure limits in the EMF directive restrict and limit the use of MRI in interventional applications (such as brain surgery) and in the imaging of vulnerable patients and children where closer patient contact is required. MRI is free from risks associated with ionizing radiation (such as x-rays), which would be used instead of MRI in many situations if the current exposure limits remain in place.
The Commission will propose a new draft directive this autumn, which will seek to remove the threat posed to the future of MRI. In 2008 implementation of the EMF directive by the member states was postponed due to concerns raised by the Alliance for MRI about the unintended impact of the legislation on the clinical and research use of MRI in Europe.
The technology
MRI is a leading technology for the diagnosis, treatment, and research of a number of diseases including cancer, cardiovascular, and neurological conditions. MRI has been used for over 25 years, imaging up to 500 million patients without harm to workers. Europe currently holds a leading position in the research and development of this technology and patients are provided with the highest standard of care.
The Alliance for MRI is a coalition of European Parliamentarians, patient groups, leading European scientists, and the medical community who together are seeking to avert the serious threat posed by the EU Physical Agents Directive 2004/40/EC (EMF) to the clinical and research use of magnetic resonance imaging (MRI) in Europe.
For more information, please contact the Alliance for MRI secretariat, Monika Hierath:
Email: monika.hierath@myesr.org
Office: 0043 1 533 40 64 20
Mobile: +43 6648349285
www.alliance-for-mri.org
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
